Fujifilm VisualSonics has received approval from Health Canada for its new ultra high-frequency (UHF) clinical ultrasound system, Vevo MD.
The company has developed new UHF ultrasound device to be used in a range of clinical applications, including neonatology, vascular, musculoskeletal, dermatology, and other small parts that are within the first 3cm of the body.
Vevo MD enables medical professionals to visualize sonograms with better image resolution, in addition to observing tiny and highly detailed anatomy.
The new ultrasound system features patented transducer technology that can operate up to 70 MHz.
Fujifilm VisualSonics parent firm Fujifilm SonoSite president and CEO Masayuki Higuchi said: “Throughout its history, Fujifilm has been at the forefront of extraordinary breakthroughs in healthcare. This powerful technology from Fujifilm VisualSonics is the latest in a long line of innovations.
“With unprecedented image resolution capabilities, Vevo MD will have significant impact on the quality of care Canadian practitioners deliver to patients.”
Fujifilm SonoSite and Fujifilm Medical Systems U.S.A. chief medical officer and senior vice president Dr Diku Mandavia said: “It is gratifying to see the Vevo MD make its clinical debut in Canada where Fujifilm partners with numerous world class hospitals.”
In 1999, Fujifilm VisualSonics was established to develop high-frequency ultrasound systems for preclinical use.
Based in Toronto of Canada, the company produces imaging technologies for use in preclinical research of different areas such as cardiovascular, oncology, neurobiology and developmental biology.
Image: Fujifilm VisualSonics’ Vevo MD UHF clinical ultrasound system. Photo: courtesy of Business Wire.